Metagenomi, Inc. Common Stock (MGX) — Cash Flow Reinvestment Rate
Metagenomi, Inc. Common Stock (MGX) has a Cash Flow Reinvestment Rate of 0.63x as of December 2022, reinvesting $42.38 Million (capex $3.51 Million plus investments $-38.87 Million) from operating cash flow of $67.73 Million. Explore how much does Metagenomi, Inc. Common Stock reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Metagenomi, Inc. Common Stock Cash Flow Reinvestment Rate (2021–2022)
Historical reinvestment intensity for Metagenomi, Inc. Common Stock across 2 annual periods. Also explore Metagenomi, Inc. Common Stock asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Metagenomi, Inc. Common Stock (2021–2022)
Year-by-year capital reinvestment analysis for Metagenomi, Inc. Common Stock. For live market cap and broader valuation context, see how much is Metagenomi, Inc. Common Stock worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 4.58x | $136.18 Million | $29.72 Million | $13.98 Million | ▲ +43.9% |
| 2021 | 3.18x | $77.22 Million | $24.26 Million | $2.90 Million | — |